GRM3 and schizophrenia: More recently, activation of mGluR3 has been reported to rescue schizophrenia-like behaviour (Dogra et al., 2024) and to counteract cognitive deficits that were caused by NMDA receptor antagonism through actions on hippocampal pyramidal neurons (Dogra et al., 2021).